Related Experiment Video
Updated: Jun 2, 2026

11:15
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
Concise review: Mesenchymal stem cell tumor-homing: detection methods in disease model systems
Michaela R Reagan1, David L Kaplan
1Department of Biomedical Engineering, Tufts University, Medford, Massachusetts 02155, USA.
Stem Cells (Dayton, Ohio)
|May 11, 2011
Summary
Mesenchymal stem cells (MSCs) show tumor-homing properties, prompting research into their use for cancer diagnostics and therapy. This review explores MSC tumor-homing mechanisms and tracking methods in animal models.
Area of Science:
- Oncology
- Stem Cell Biology
- Medical Imaging
Background:
- Cancer metastasis remains a primary cause of cancer-related deaths, underscoring the need for novel diagnostic and therapeutic strategies.
- Mesenchymal stem cells (MSCs) exhibit a natural tendency to home to tumor sites, presenting a promising avenue for cancer research.
- Understanding MSC tumor-homing mechanisms is crucial for leveraging their potential in cancer treatment and diagnostics.
Purpose of the Study:
- To review the reasons behind mesenchymal stem cell (MSC) tumor-homing.
- To examine the pro-tumor and anti-tumor effects associated with MSCs.
- To explore the application of MSC tumor-homing for developing cell-based cancer diagnostics and therapies.
Main Methods:
- Review of existing literature on MSCs in regenerative medicine and tumor-homing contexts.
- Discussion of MSC delivery and genetic labeling techniques for creating tissue model systems.
- Evaluation of various tracking (detection) methodologies, including non-optical (MRI, PET, SPECT) and optical (fluorescence, bioluminescence) imaging in animal models.
Main Results:
- MSCs possess inherent tumor-homing capabilities that can be studied and potentially exploited.
- Different tracking methods offer distinct advantages and disadvantages for monitoring MSCs in vivo.
- The choice of tracking methodology impacts the assessment of MSC behavior and therapeutic potential in disease models.
Conclusions:
- Mesenchymal stem cell (MSC) tumor-homing is a significant area of research with potential for cancer diagnostics and therapy.
- Animal models and advanced tracking technologies are essential for elucidating MSC behavior and efficacy.
- Further research is needed to optimize MSC-based strategies for improved cancer patient outcomes.
